Genprex, Inc. Share Price
NASDAQ: GNPX | Micro CapGenprex, Inc. Stock Performance
Genprex, Inc. Share Price Today
As of 30 October 2026, Genprex, Inc.'s share price is $2.06. The stock opened at $2.04, compared to its previous close of $2.00. During today's trading session, Genprex, Inc.'s share price traded between $2.04 and $2.04, with an average price of $2.04. Over the past 52 weeks, the stock has recorded a high of $8.08 and a low of $0.43. In terms of performance, Genprex, Inc.'s share price has risen by 111.72% over the last six months and is down 64.36% on a year-on-year basis.
Genprex, Inc. Share Price Chart
Genprex, Inc. Quarterly Profit & Loss
All figures in USD
Genprex, Inc. Annual Profit & Loss
All figures in USD
About Genprex, Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
Genprex, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.83 | $2.04 | -30.85% |
Sep 2026 | $3.56 | $2.95 | -26.98% |
Aug 2026 | $4.87 | $4.04 | -32.21% |
Jul 2026 | $0.55 | $5.96 | +1,059.53% |
Jun 2026 | $0.76 | $0.51 | -34.10% |
May 2026 | $0.94 | $0.78 | -19.84% |
Apr 2026 | $1.75 | $0.97 | -44.87% |
Mar 2026 | $1.90 | $1.76 | -11.75% |
Feb 2026 | $2.67 | $2.00 | -24.53% |
Jan 2026 | $1.77 | $2.65 | +52.30% |
Dec 2025 | $2.85 | $1.74 | -40.61% |
Nov 2025 | $5.76 | $2.93 | -49.31% |